New Leaf Biopharma Opportunities II, L.P.

New Leaf Biopharma Opportunities II, L.P. discloses dealings in Harpoon Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 25 October 2023 to 11 March 2024, the count stands at 5 filings.

On the market, this insider has only ever bought: 2 purchases. No amount is published for 2 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

The record was last updated on 11 March 2024 with a transaction in Harpoon Therapeutics, Inc. The clock since the last published purchase (27 October 2023) now reads 1,108 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.